MedPath
TGA Approval

LUCENTIS ranibizumab (rbe)1.65 mg/0.165 mL solution for injection prefilled syringe (212387)

212387

LUCENTIS ranibizumab (rbe)1.65 mg/0.165 mL solution for injection prefilled syringe

Novartis Pharmaceuticals Australia Pty Ltd

November 5, 2013

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/81261cdc97e6e5f483af59e5c4c48e23.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/21ee801642d6bf4d4565f233d7e7409a.pdf

Active Ingredients

Ranibizumab

© Copyright 2025. All Rights Reserved by MedPath